Healthcare
The COVID-19 pandemic has stress-tested and placed the spotlight on the global healthcare system. This renewed focus will drive reforms and open investment opportunities for ASEAN’s healthcare sector, particularly in the fields of biotechnology, telehealth, pharmaceuticals, and diagnostic medicine.
MMDoc is our first step into this vast market. In collaboration with China's UMP Healthcare and Hong Kong's Creo Capital, we have devised a holistic approach into the ASEAN market. Our 4-pronged approach focuses on
- General Practitioner Services
- Pharmaceutical Services
- Door-to-Door Testing & Vaccination Services
- Telehealth Services
